Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs
COVID-19 is spreading rapidly yet there is no clinically proven drug available now. Soil-derived Streptomyces sp. GMR22 has a large genome size (11.4 Mbp) and a huge BGCs (Biosynthetic Gene Clusters) encoding secondary metabolites. This bacterium is a potential source for producing a wide variety of...
Guardado en:
Autores principales: | Yohana Nadia Melinda, Jaka Widada, Tutik Dwi Wahyuningsih, Rifki Febriansah, Ema Damayanti, Mustofa Mustofa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e1f81f8991b24cd881baec6247e961fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antiplasmodial Activity of The Low Molecular Weight Compounds from Streptomyces sp. GMR22
por: Tarsa Ruli Tambunan, et al.
Publicado: (2020) -
Genomic and Chemical Diversity of <named-content content-type="genus-species">Bacillus subtilis</named-content> Secondary Metabolites against Plant Pathogenic Fungi
por: Heiko T. Kiesewalter, et al.
Publicado: (2021) -
Antiplasmodial activity, biosynthetic gene clusters diversity, and secondary metabolite constituent of selected Indonesian Streptomyces
por: Ema Damayanti, et al.
Publicado: (2021) -
Antimicrobial activity of ethyl acetate extracts of Streptomyces sp. CRB46 and the prediction of their bioactive compounds chemical structure
por: Ambarwati Ambarwati, et al.
Publicado: (2020) -
Antagonistic activity of terrestrial Streptomyces sp. VITNK9 against Gram negative bacterial pathogens affecting the fish and shellfish in aquaculture
por: Ishaque Nabila,Mohammed, et al.
Publicado: (2018)